Cargando…
Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats
Subchronic treatment with the N-methyl-d-aspartate (NMDA) antagonist phencyclidine (PCP) produces behavioral abnormalities in rodents which are considered a reliable pharmacological model of neurocognitive deficits in schizophrenia. Alterations in prefrontal neuronal firing after acute PCP administr...
Autores principales: | Young, A.M.J., Stubbendorff, C., Valencia, M., Gerdjikov, T.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317768/ https://www.ncbi.nlm.nih.gov/pubmed/25542422 http://dx.doi.org/10.1016/j.neuroscience.2014.12.014 |
Ejemplares similares
-
Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition
por: Xiao, Xiaolin, et al.
Publicado: (2011) -
Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia
por: Asif-Malik, Aman, et al.
Publicado: (2017) -
Chronic Phencyclidine Increases Synapsin-1 and Synaptic Adaptation Proteins in the Medial Prefrontal Cortex
por: Pickering, Chris, et al.
Publicado: (2013) -
Phencyclidine Disrupts the Auditory Steady State Response in Rats
por: Leishman, Emma, et al.
Publicado: (2015) -
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice
por: Rodríguez-Vega, Andrés, et al.
Publicado: (2023)